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Simulations of the molecular dynamics of the [Mets]enkephalin monomer and dimer structures in water have been carried 
out. The dynamic trajectories have been analyzed in terms of the distances between intra- or intermolecular polar atoms. 
The time-correlated conformational transitions of an extended monomer structure have been converged into a stationary 
state among the B-bend folded forms. However, the dynamics simulation of an extended antiparallel dimer structure has 
shown no noticeable conformation change. These results imply that both the /?-bend monomer and the extended dimer 
structures exist together as the fundamental conformation of enkephalins. 
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1. INTRODUCTION 
[Met’]-(Tyr-Gly-Gly-Phe-Met) and [Leu’len- 
kephalins (Tyr-Gly-Gly-Phe-Leu) are two endo- 
genous pentapeptides exhibiting morphine-like 
actions [ 11. Although their physiological effects 
derive from their interaction with the opioid recep- 
tor, it is well known [2] that there are several 
subclasses such as p-, S- and x-receptors. In order 
to effectively design new and potent opioid com- 
pounds, therefore, it is of particular importance to 
elucidate the active conformation for each type of 
receptor. 
As a fundamental conformation of enkephalins, 
X-ray crystallographic studies [3-91 have 
presented the following two forms: a type I ’ ,8- 
bend monomeric structure and an extended an- 
tiparallel dimer structure. The conformational 
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comparison with p-selective morphine [3,5] has 
suggested that the former structure of the 
enkephalin is responsible for binding with the p- 
receptor. On the other hand, many chemically syn- 
thesized d-selective opioid peptides have shown an 
extended antiparallel molecular aggregation [lo], 
suggesting that the latter dimer structure of the 
enkephalin corresponds to a conformation suitable 
for binding with the d-receptor. 
Previous studies of the active conformation of 
the enkephalin in relation to the receptor selectivity 
have generally taken its monomer structure into 
account. It could be supposed that there is no 
direct evidence that the dimer structure exists at the 
physiological concentration. Nevertheless, our 
previous studies [8,10,11] have pointed to the im- 
portance of the dimer structure as a biologically 
active conformation. Consequently, to determine 
whether the dimer structure stably exists in a dilute 
aqueous solution could provide the evidence need- 
ed, although this is difficult to define ex- 
perimentally. 
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Simulation of molecular dynamics is a useful ap- 
proach to examine the conformation of a flexible 
molecule. It can describe the molecular system in 
terms of its trajectory or an ensemble of conforma- 
tions. This method is assumed to be an adequate 
representation of the distribution function, and 
therefore provides reliable information about the 
molecular motion as exemplified in the dynamic 
properties of nucleic acid and proteins. In this 
paper, dealing with the molecular dynamics 
simulations of both monomeric and dimeric struc- 
tures of [Met’]enkephalin, we emphasize that the 
dimer structure itself exists stably in water and ex- 
hibits different conformational behaviours from 
those of a monomer structure. 
2. EXPERIMENTAL 
Molecular dynamics simulations of monomeric and dimeric 
[Met’lenkephalin including water and using t = 1 were carried 
out using the computer program AMBER [12]. Initial structures 
for an extended monomer and an extended antiparallel dimer 
were constructed using the X-ray crystal analysis of 
[Met5]enkephalin [8]. The initial enkephalin structures were 
energy-refined with conjugate gradient minimization. A total of 
321 (monomer) or 280 (dimer) water molecules within a sphere 
of a 13 A (monomer) or 14 A (dimer) radius were placed 
around the solute enkephalin conformation. These molecules 
were designed so as to prevent leakage from the system by a 
boundary force of 1 kcal/mol per A. 
The dynamics simulations were begun assuming random 
velocity of the atoms that followed a Maxwellian distribution at 
300 K. Equilibration of the water molecules was performed in 
16 ps, and the simulations were continued with a 0.4 ps-’ 
temperature coupling for 50 ps (monomer) or 60 ps (dimer) us- 
ing a nonbonded cutoff of 10 A. The time step of the dynamics 
was 0.8 fs, and a Verlet’s integrator algorithm [13] was used to 
solve Newton’s equations of motion by numerical integration. 
The simulations were carried out on a VAX8600 computer, and 
an IRIS3130 instrument was used to display the conformational 
graphs. 
3. RESULTS AND DISCUSSION 
As a result of high flexibility of linear peptides, 
many conformations of the enkephalin monomer 
are possible. However, the conformational trajec- 
tory, monitored by the time profiles of four in- 
tramolecular atomic distances (fig. l), shows the 
transition from the initial extended form to the 
folded one (~27 ps) through an intermediate state 
(7-25 ps). The conformational event for each 
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Fig.1. Time profiles of four atomic distances for the enkephalin monomer. (Inset) Time profile of the total potential energy 
accompanying the conformational transition. 
272 
Volume 239, number 2 FEBS LETTERS November 1988 
stage is characterized by the formations of a 
Gly’(C = 0). . . Phe4(NH) y-bend structure (7-25 
ps, fig.ld) and two further hydrogen bonds of 
Tyr’(NH$) with Phe4(C = 0) (fig.lb) and 
Met’(COO-) (fig.la), respectively. Representative 
photographs of each stage are shown in fig.2. The 
conformation of the main chain at the stationary 
state (>27 ps) shows no significant conformation 
change even during further dynamics simulation, 
and belongs to a typical type I ’ &bend structure, 
although no intramolecular hydrogen bond is 
formed between the Tyr’(C=O) and Phe4(NH) 
atoms (fig.lc). This &bend conformation of the 
enkephalin monomer is in good agreement with 
that found in the X-ray crystal structure [3,5]. The 
approach between Tyr’ and Phe4 aromatic rings 
caused by taking a P-bend conformation forms a 
hydrophobic core at the Gly2-Gly3 P-bend moiety, 
as seen in fig.2b. This may be related to the 
emergence of the activity, judging from the fact 
that these amino acid residues are essential for 
opioid activity. The total potential energy change 
accompanying the conformational transition is 
shown in fig.1 (inset). It is obvious that the 
monomer structure of enkephalin overwhelmingly 
assumes an ensemble of folded forms in an 
aqueous solution. 
(b) 
Fig.2. (a) Photographs of monomeric enkephalin conforma- 
tions at 0, 11 and 47 ps. Thin lines indicate the possible 
intramolecular hydrogen bonds. (b) Molecular distributions of 
inner waters within 4 A from any atom of enkephalin at 47 ps 
simulation. 
Different experimental results have suggested 
that extended and folded conformations of 
enkephalin occur in equilibrium within a solution 
rather than in a single preferred conformation 
[14]. The dynamics simulation of the extended an- 
tiparallel dimer structure in water, as the biological 
representative of an enkephalin extended confor- 
mation, has been carried out. The conformational 
trajectory was monitored by time profiles of four 
distances of Tyri(NHi). . .Met:(COO-) (fig.3a), 
TyrB(NH$). . .Me&COO-) (fig.3b), Tyri- 
(NH:). . . Me&COO-) (fig.3c) and TyrB- 
(NH:). . . Me&COO-) (fig.3d) atomic pairs, where 
the subscript letters, A and B, each denote an 
enkephalin molecule in the dimer structure. The 
results, along with the total potential energy 
change as a function of simulation time, are shown 
in fig.3. The starting structure (0 ps) and the 
photographs taken at 30 ps and 60 ps are shown in 
fig.4. Interestingly, the extended antiparallel dimer 
structure is essentially maintained throughout the 
dynamics simulation from 0 to 60 ps, although 
each molecule in the dimer itself shows a con- 
siderable amount of elasticity (see fig.3a and b). 
Each molecule in the dimer is tightly linked with its 
neighbour by two hydrogen bonds between the ter- 
minal NH: and COO- groups (see fig.3c and d). 
These hydrogen bonds have also been observed by 
the ‘H NMR analysis of the d-receptor selective 6- 
Fig.3. Time profiles of four atomic distances for the enkephalin 
dimer. (Inset) Time profile of the total potential energy 
accompanying the conformational transition. 
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0 PS 
Fig.4. Stereoscopic photographs of dimeric enkephalin conformations at 0, 30 and 60 ps. Thin lines indicate the possible intermolecular 
hydrogen bonds. Water molecules are omitted for the sake of clarity. 
enkephalin (Tyr-D-Thr-Gly-Phe-Leu-Thr) [lo]. 
The total potential energy change accompanying 
the conformational transition is very small and, 
therefore, it would be reasonable to consider that 
the dimer structure observed in crystal structures 
of enkephalins [4,6-91 can be smoothly trans- 
formed from the elastic form in the solution state 
without large loss of energy. 
The mean directions (MD) and their angular 
standard deviations (ASD) [ 151 of all side-chain 
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Table 1 
Torsional variations (degree) of enkephalin side-chains 
November 1988 
Torsion Tyr ~ Phe 4 Met ~ 
XI X2 1 X2 1 X2 X3 
Monomer 
MD 56.9 -96.2 61.2 93.6 
ASD 21.3 21.8 16.9 23.8 
Dimer molecule A 
MD -47.3 -64.0 56.2 91.3 
ASD 53.2 32.2 14.9 23.7 
Dimer molecule B 
MD 58.5 -91.3 71.5 -58.9 
ASD 22.1 18.7 15.7 24.9 
58.3 - 176.3 37.5 
18.6 24.0 84.5 
65.3 - 176.1 - 132.9 
15.5 21.2 96.5 
- 66.9 179.0 179.4 
15.3 31.2 17.0 
to rs ion  angles for  monomer  and d imer  structures 
are l isted in table 1. They  show relat ively large 
ASDs  around their  MDs ,  many  o f  which corre-  
spond to the energet ica l ly  stable conformat ions .  
This  impl ies that  the s ide-chain tors ions rotate con-  
s iderably  wi th in  their  preferab le  regions and thus 
are relat ively f lexible. 
In  conc lus ion ,  the present  s imulat ion  o f  
mo lecu la r  dynamics  prov ides  impor tant  insight in- 
to the d imer  structure o f  enkephal ins .  These struc- 
tures never  d issociate f rom each other ,  even when 
they exist in a di lute aqueous  so lut ion.  The  fun-  
damenta l  conformat ions  o f  enkephal ins  were 
determined  as the f l -bend monomer  fo rm and the 
extended ant ipara l le l  d imer  structure.  Accord ing-  
ly, this result  can account  for  the conf l ic t ing con-  
c lus ions presented in prev ious  so lut ion studies on 
the stable conformat ion  o f  enkephal ins  [14]. This 
paper  fur ther  indicates a b io log ica l  impl icat ion  for 
the d iscuss ion on enkepha l in  monomer  and d imer  
structures with respect to the op io id  receptor  
mul t ip l ic i ty  [4,5,8,11,16,17].  
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